Correlation Between Aceragen and Processa Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aceragen and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aceragen and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aceragen and Processa Pharmaceuticals, you can compare the effects of market volatilities on Aceragen and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aceragen with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aceragen and Processa Pharmaceuticals.

Diversification Opportunities for Aceragen and Processa Pharmaceuticals

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aceragen and Processa is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Aceragen and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Aceragen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aceragen are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Aceragen i.e., Aceragen and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Aceragen and Processa Pharmaceuticals

Given the investment horizon of 90 days Aceragen is expected to under-perform the Processa Pharmaceuticals. In addition to that, Aceragen is 1.06 times more volatile than Processa Pharmaceuticals. It trades about -0.06 of its total potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.02 per unit of volatility. If you would invest  3,800  in Processa Pharmaceuticals on September 3, 2024 and sell it today you would lose (3,684) from holding Processa Pharmaceuticals or give up 96.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy30.91%
ValuesDaily Returns

Aceragen  vs.  Processa Pharmaceuticals

 Performance 
       Timeline  
Aceragen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aceragen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Aceragen is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Processa Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Aceragen and Processa Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aceragen and Processa Pharmaceuticals

The main advantage of trading using opposite Aceragen and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aceragen position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.
The idea behind Aceragen and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stocks Directory
Find actively traded stocks across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Global Correlations
Find global opportunities by holding instruments from different markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world